Report Subject - Pharma Sales - Page 1

Learn More Effective Pharma KAM Teams: Challenges and solutions from the front line (2016)

The essentials for getting your KAM strategy right There are many factors currently affecting KAM initiatives - lack of buy-in from internal stakeholders, poorly understood customer needs and an inability to creatively...

Compare
Learn More Reshaping the Pharma Sales Force: A blueprint for contemporary sales and service models

The long-standing, universal model of the pharma sales force has been declared dead. Selling products today is much more complicated than simply putting an army of sales reps on the street and directing them to pursue...

Compare
Learn More Patient-Centric Mobile Apps: Key Opportunities and Challenges for Pharma

Dozens of new health apps for smartphones and tablets are produced monthly. Hundreds of thousands already exist. What does it take for a patient app to stand out in this crowded space? What are the essential ingredients...

Compare
Learn More Trends and Innovations in Key Account Management

KAM is the desired model to deliver the demands of today’s customers. And as the shift of prescribing power from physician to integrated decision-making intensifies it fuels demand for more specialised account...

Compare
Learn More Commercial Excellence in Rare Diseases and Orphan Drugs

Developing therapies for orphan diseases is attracting much industry interest with the promise of profits. But what are the specific R&D, regulatory, stakeholder and market access issues you need to understand and...

Compare
Learn More Trends and Innovations in Sales Force Effectiveness

What makes an ideal modern pharma sales representative and what skills, knowledge, tools, training and incentives will make them really effective? Trends and Innovations in Sales Force Effectiveness is an important...

Compare
Learn More Trends and Innovations in Patient Adherence

Taking the right dose of the right medicine at the right time is key to improving health outcomes, so why do so many patients fail to adhere to their treatment programme? Trends and Innovations in Patient Adherenceis a...

Compare
Learn More Trends and Innovations in Drug Pricing

FirstWord’s Trends and Innovations in Drug Pricing report dissects international trends and examines how long-standing dynamics in competitive pricing and access will strengthen the payer position in demanding...

Compare
Learn More FirstWord FirstPolls: Tweet dreams – do physicians share enthusiasm for pharma engagement via social media?

Based on a recent survey to physicians, gain access to feedback on a variety of questions regarding pharma social media engagement. New FDA Guidance In early 2014 the FDA provided long awaited...

Compare
Learn More Trends in Measuring and Rewarding KAM Team Performance

Key account managers (KAMs) are the new face of pharma sales. Whether meeting with hospital administrators, managed care operators, private payers or supporting regionally-based accounts, KAMs build relationships...

Compare
Learn More Pharma-Patient Engagement: insights from patient opinion leaders

Patients and Pharma want the same thing, but for different reasons. Patients want access, support and information about the latest drugs while Pharma needs market access for sales and profits that will to fund more...

Compare
Learn More Value-driven Pharma: Integrating health outcomes across the product lifecycle

Two recessions in a decade, financial austerity, and unprecedented pressure to prove product value to all stakeholders. There is no question that the pharma game has changed in the new “Outcomes Era”, in...

Compare
Learn More Effective Pharma KAM Teams - the essential factors driving performance

The goal remains the same: pharmaceutical companies wants to influence product adoption, improve sales volume and increase product revenue. Key Account Management (KAM) is now the tool of choice, but too many companies...

Compare
Learn More Commercialisation of Biosimilars: strategies for market penetration

Times, they are a-changin’—at least for the American biological product market. With five major biological products worth a collective US$35 billion in annual sales now facing imminent patent expiration, the...

Compare
Learn More Strategies for Working With Real World Data

Real world data (RWD)—it’s a never-ending wave of information that is, increasingly, transforming healthcare into ‘reality medicine’ that responds to the real world use of medicines rather than...

Compare
Learn More Pharma and Gamification: motivating positive outcomes a primer

Gamification is coming of age and Pharma companies need to understand how it can help all levels of their business. When is a game not a game? When its gamification. Gamification is not about creating games. It is about...

Compare

Browse by